416 related articles for article (PubMed ID: 25441266)
1. Oncogenic Osteomalacia From a Primary Phosphaturic Mesenchymal Tumor of the Toe: A Case Report.
Kim I; Rajani R
J Foot Ankle Surg; 2016; 55(2):294-8. PubMed ID: 25441266
[TBL] [Abstract][Full Text] [Related]
2. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic osteomalacia: two case reports with surprisingly different outcomes.
Seijas R; Ares O; Sierra J; Pérez-Dominguez M
Arch Orthop Trauma Surg; 2009 Apr; 129(4):533-9. PubMed ID: 19125258
[TBL] [Abstract][Full Text] [Related]
4. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
[TBL] [Abstract][Full Text] [Related]
5. Osteomalacia induced by a phosphaturic mesenchymal tumor secreting fibroblast growth factor 23.
Nagae K; Uchi H; Ito T; Moroi Y; Oda Y; Furue M
Eur J Dermatol; 2015 Apr; 25(2):199-200. PubMed ID: 25788099
[No Abstract] [Full Text] [Related]
6. Thoracic phosphaturic mesenchymal tumors causing oncogenic osteomalacia.
Puthenveetil PJ; Hattab EM; Peacock M; Horn EM
J Clin Neurosci; 2013 Aug; 20(8):1057-61. PubMed ID: 23618679
[TBL] [Abstract][Full Text] [Related]
7. Tumor-induced osteomalacia: experience from a South American academic center.
González G; Baudrand R; Sepúlveda MF; Vucetich N; Guarda FJ; Villanueva P; Contreras O; Villa A; Salech F; Toro L; Michea L; Florenzano P
Osteoporos Int; 2017 Jul; 28(7):2187-2193. PubMed ID: 28341900
[TBL] [Abstract][Full Text] [Related]
8. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
[TBL] [Abstract][Full Text] [Related]
9. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
[TBL] [Abstract][Full Text] [Related]
10. Tumor-induced osteomalacia: a case report.
Aligail K; Dave JA; Ross IL
J Med Case Rep; 2022 Jan; 16(1):22. PubMed ID: 35016725
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt.
Seemann L; Padala SA; Mohammed A; Belayneh N
J Investig Med High Impact Case Rep; 2019; 7():2324709619895162. PubMed ID: 31850815
[TBL] [Abstract][Full Text] [Related]
12. The Right Leg that Troubled the Left Leg.
B S; V A
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116017
[TBL] [Abstract][Full Text] [Related]
13. Osteomalacia-Inducing Tumors of the Brain: A Case Report, Review and a Hypothesis.
Fathalla H; Cusimano M; Di Ieva A; Karamchandani J; Fung R; Kovacs K
World Neurosurg; 2015 Jul; 84(1):189.e1-5. PubMed ID: 25746588
[TBL] [Abstract][Full Text] [Related]
14. [Hypophosphatemic osteomalacia].
Bullmann C; Benker G; Rosien U; Delling G; Siggelkow H; Schulte HM
Med Klin (Munich); 2008 Sep; 103(9):671-5. PubMed ID: 18813890
[TBL] [Abstract][Full Text] [Related]
15. Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature.
Woo VL; Landesberg R; Imel EA; Singer SR; Folpe AL; Econs MJ; Kim T; Harik LR; Jacobs TP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):925-32. PubMed ID: 19828339
[TBL] [Abstract][Full Text] [Related]
16. Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia - diagnostic challenges and clinical outcomes.
Dutta D; Pandey RK; Gogoi R; Solanki N; Madan R; Mondal A; Dogra S; Thapa P
Endokrynol Pol; 2018; 69(2):205-210. PubMed ID: 29442350
[TBL] [Abstract][Full Text] [Related]
17. The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?
Ledford CK; Zelenski NA; Cardona DM; Brigman BE; Eward WC
Clin Orthop Relat Res; 2013 Nov; 471(11):3618-25. PubMed ID: 23868423
[TBL] [Abstract][Full Text] [Related]
18. Tumor-induced hypophosphatemic osteomalacia caused by a mesenchymal tumor of the mandible managed by a segmental mandibulectomy and microvascular reconstruction with a free fibula flap.
Acharya RP; Won AM; Moon BS; Flint JH; Roubaud MS; Williams MD; Hessel AC; Murphy WA; Chambers MS; Gagel RF
Head Neck; 2019 Jun; 41(6):E93-E98. PubMed ID: 30859653
[TBL] [Abstract][Full Text] [Related]
19. Identifying the culprit lesion in tumor induced hypophosphatemia, the solution of a clinical enigma.
Slot-Steenks MM; Hamdy NA; van de Sande MA; Vriens D; Cleven AH; Appelman-Dijkstra NM
Endocrine; 2016 Dec; 54(3):642-647. PubMed ID: 27709474
[TBL] [Abstract][Full Text] [Related]
20. Reports of 17 Chinese patients with tumor-induced osteomalacia.
Yu WJ; He JW; Fu WZ; Wang C; Zhang ZL
J Bone Miner Metab; 2017 May; 35(3):298-307. PubMed ID: 27085966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
